Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Equity Average (2018 - 2025)

Catheter Precision has reported Equity Average over the past 8 years, most recently at $6.7 million for Q4 2025.

  • Quarterly Equity Average fell 45.36% to $6.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Dec 2025, down 45.36% year-over-year, with the annual reading at $9.2 million for FY2025, 44.13% down from the prior year.
  • Equity Average was $6.7 million for Q4 2025 at Catheter Precision, up from $6.7 million in the prior quarter.
  • Over five years, Equity Average peaked at $29.8 million in Q2 2023 and troughed at $6.7 million in Q3 2025.
  • The 5-year median for Equity Average is $16.2 million (2022), against an average of $15.8 million.
  • Year-over-year, Equity Average surged 113.82% in 2023 and then tumbled 55.95% in 2025.
  • A 5-year view of Equity Average shows it stood at $17.6 million in 2021, then crashed by 38.19% to $10.9 million in 2022, then surged by 97.8% to $21.5 million in 2023, then tumbled by 42.91% to $12.3 million in 2024, then crashed by 45.36% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Equity Average are $6.7 million (Q4 2025), $6.7 million (Q3 2025), and $7.2 million (Q2 2025).